Editorial Policies

Peer review and editorial decisions

Single-blind by default; double-blind review is available on request.

All submissions undergo initial editorial screening. Manuscripts that meet the journal's scope and minimum requirements proceed to independent peer review. Manuscripts that proceed to external peer review are normally evaluated by at least two independent subject-matter experts.

In single-blind review, reviewers know the authors' identities and authors are not told the reviewers' identities. Authors who request double-blind review prepare an anonymized manuscript as described in the Instructions for Authors; when double-blind review is requested, editors ensure that author-identifying information is not shared with reviewers.

Editorial decisions are based on scope, scientific quality, methodological rigor, ethical compliance, reporting quality, and relevance to the journal. The handling editor makes the decision, informed by the reviewers' reports, under the oversight of the Editor-in-Chief. Decisions are to accept, to request minor or major revision, or to reject. Reviewers' comments are shared with the authors, and reviewers' identities remain confidential. Guidance is given in the Reviewer Guidelines and Editors Guidelines.

Editorial independence

Editorial decisions rest with the journal's editors and are independent of the article processing charge, of any fee-relief inquiry and of commercial considerations. Manuscripts submitted by the Editor-in-Chief, members of the editorial board or their close collaborators are handled by an editor without a conflict of interest, and the submitting editor takes no part in their review or decision.

Publication ethics

JDRT follows the guidance of the Committee on Publication Ethics (COPE) and the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals. Concerns about plagiarism, data fabrication or falsification, image manipulation, duplicate or redundant publication, citation manipulation and undisclosed conflicts of interest are investigated following COPE guidance, and may lead to rejection, correction or retraction.

Research involving human participants

Research involving human participants, identifiable human data or human biological material, including skin biopsies and tissue samples, requires approval from an appropriate research ethics committee or institutional review board, where applicable. The manuscript names the committee, gives the approval reference number, and states that informed consent was obtained, or a waiver documented by the ethics committee, where applicable. Research is conducted in accordance with the Declaration of Helsinki, where applicable.

Case Reports and Clinical Images require informed consent for publication from the patient or a legal guardian, or a waiver documented by the ethics committee, where applicable. Identifying features are removed unless they are essential and covered by that consent; eyes are masked unless essential to the diagnosis.

Interventional clinical trials must be registered in an accepted public trial registry at or before the first participant provides consent for enrollment. The registry name, registration number, and registration date must be reported in the manuscript.

Research involving animals

Studies involving animals, including experimental disease models, require prior approval from the relevant institutional animal care and use committee or animal ethics committee, stated in the manuscript with the approval reference number. The work complies with applicable animal-welfare regulations, applies the 3Rs (Replacement, Reduction and Refinement) and is reported in line with the ARRIVE guidelines.

Authorship and contributions

Authorship follows the ICMJE criteria: each author has made a substantial contribution to the work, has drafted or critically revised it, has approved the final version and agrees to be accountable for it. Contributions are described with the CRediT taxonomy, and people who contributed without meeting the criteria are acknowledged. Changes to the author list after submission require the written agreement of every author and are handled by the editorial office.

Conflicts of interest and funding

Authors disclose all financial and non-financial interests that could be seen to influence the work, including relationships with pharmaceutical, device and cosmetic companies, and describe every source of funding together with the role of the funder. Disclosures are published with the article. Editors and reviewers declare any conflict of interest with a manuscript and are recused from handling it.

Research integrity and originality

Submitted manuscripts are screened with Crossref Similarity Check, powered by iThenticate. Editors assess each similarity report in context, including overlap with the authors' own earlier work, before deciding how to proceed.

Manuscripts report original work that has not been published elsewhere and is not under consideration by another journal. Posting a preprint is compatible with submission; authors cite the preprint in the cover letter. Clinical and microscopy images are not manipulated beyond adjustments applied to the whole image and described in the legend.

Data availability and reporting

Every empirical research manuscript must include a data-availability statement.

The statement explains where the data supporting the results can be found, such as a repository with a persistent identifier, or the conditions under which they can be accessed when ethics approval or participant consent restricts sharing. Deposit in a recognized repository is encouraged. Research is reported following the guideline that matches its design, for example CONSORT, STROBE, PRISMA, STARD or CARE, and the completed checklist is submitted with the manuscript where applicable.

Use of artificial intelligence

Generative artificial intelligence (AI) and large-language-model tools are not listed as authors. Authors disclose any use of AI tools in preparing the manuscript, analyzing data or producing figures, naming the tool and describing its use in the Methods or Acknowledgments, and remain responsible for the accuracy, originality and integrity of the work.

Editors and reviewers keep manuscripts confidential. Reviewers must obtain journal permission before using AI to assist with a review. Any permitted use must be disclosed, and confidential manuscript content must not be uploaded where confidentiality cannot be assured.

Corrections and retractions

When an error or concern about a published article is identified, the journal publishes a correction, an expression of concern or a retraction, following the COPE retraction guidelines. Each notice is linked to the original article, and a retracted article remains available with the retraction clearly marked. Authors who find an error in their published work contact the editorial office.

Appeals and complaints

Authors may appeal an editorial decision by writing to the editorial office with a reasoned case that responds to the editors' and reviewers' comments. Each appeal is assessed by an editor who was not involved in the original decision, who may seek additional review.

Complaints about the journal's processes, editors or publications are acknowledged, investigated confidentially and answered in writing. Appeals and complaints are sent to info@openaccesspub.org.

Open access, license and copyright

JDRT is an open-access journal. All articles are free to read, download, copy and distribute from the day of publication, without subscription or registration.

Articles are published under the Creative Commons Attribution 4.0 International license (CC BY 4.0), which permits anyone to share and adapt the work for any lawful purpose, provided the authors and the original publication are credited. Authors retain copyright in their work. Authors may deposit any version of their article, including the published version, in institutional or subject repositories without embargo.

Fees

The article processing charge is USD 1,499 for every article type. It is payable only after acceptance; withdrawal after submission is subject to the journal's withdrawal policy.

Editorial decisions are independent of the charge and of any fee-relief inquiry. The charge and the withdrawal terms are set out on the Article Processing Charges page.

Digital preservation

JDRT articles will be deposited in Portico, a not-for-profit digital-preservation archive run by ITHAKA, so that the published record remains available for the long term. Each article also carries a Crossref DOI that resolves to its current location. Read our preservation policy.